Platform technologies facilitate development and accelerate commercialization of protein therapeutics. Speed to market is essential in the biopharmaceutical industry today. Manufacturers are seeking mechanisms for increasing efficiencies and reducing costs without compromising the safety and efficacy of their drug products. In addition to exploring novel production methods such as continuous processes and disposable production technology, manufacturers also heavily invest in platform technologies for protein expression that will not only facilitate the development, but also increase yield and speed to market.
Read the full article here.